Free Trial

Microvast (MVSTW) Financials

$0.35 +0.05 (+15.41%)
As of 05/23/2025 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Microvast

Annual Income Statements for Microvast

This table shows Microvast's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-195 -106 -158
Consolidated Net Income / (Loss)
-195 -106 -158
Net Income / (Loss) Continuing Operations
-195 -106 -158
Total Pre-Tax Income
-195 -106 -158
Total Revenue
380 308 204
Net Interest Income / (Expense)
-8.97 0.98 -0.14
Total Interest Income
0.74 3.61 3.18
Investment Securities Interest Income
0.74 3.61 3.18
Total Interest Expense
9.71 2.63 3.32
Long-Term Debt Interest Expense
9.71 2.63 3.32
Total Non-Interest Income
389 307 204
Net Realized & Unrealized Capital Gains on Investments
9.41 0.00 0.00
Other Non-Interest Income
380 307 204
Total Non-Interest Expense
576 413 363
Marketing Expense
64 69 66
Other Operating Expenses
342 346 298
Impairment Charge
93 0.50 1.80
Other Special Charges
77 -2.01 -2.65
Income Tax Expense
0.00 0.01 0.03
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 -0.08 0.00
Basic Earnings per Share
($0.61) ($0.34) ($0.52)
Weighted Average Basic Shares Outstanding
318.46M 310.91M 303.28M
Diluted Earnings per Share
($0.61) ($0.34) ($0.52)
Weighted Average Diluted Shares Outstanding
318.46M 310.91M 303.28M
Weighted Average Basic & Diluted Shares Outstanding
325.21M 317.21M 309.41M

Quarterly Income Statements for Microvast

This table shows Microvast's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q1 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-82 13 -102 -25 -25 -26 -26 -30 -34 -37 -
Consolidated Net Income / (Loss)
-82 13 -102 -25 -25 -26 -26 -30 -34 -37 -
Net Income / (Loss) Continuing Operations
-82 13 -102 -25 -25 -26 -26 -30 -34 -37 -
Total Pre-Tax Income
-82 13 -102 -25 -25 -26 -26 -30 -34 -37 -
Total Revenue
121 97 82 80 104 80 76 48 66 39 -
Net Interest Income / (Expense)
-1.40 -4.10 -1.85 -1.61 -1.06 0.09 1.03 0.92 0.72 0.10 -
Total Interest Income
0.19 0.19 0.25 0.12 0.13 0.58 1.52 1.38 1.58 0.87 -
Investment Securities Interest Income
0.19 0.19 0.25 0.12 0.13 0.58 1.52 1.38 1.58 0.87 -
Total Interest Expense
1.60 4.29 2.09 1.73 1.19 0.49 0.49 0.46 0.86 0.77 -
Long-Term Debt Interest Expense
1.60 4.29 2.09 1.73 1.19 0.49 0.49 0.46 0.86 0.77 -
Total Non-Interest Income
123 101 84 81 105 80 75 47 65 39 -
Other Non-Interest Income
113 101 84 81 105 80 75 47 65 39 -
Total Non-Interest Expense
204 84 183 105 127 106 102 77 100 75 -
Marketing Expense
16 16 15 17 18 19 15 16 16 17 -
Other Operating Expenses
94 80 80 88 109 87 87 63 82 59 -
Other Special Charges
89 -11 0.23 -0.44 -0.21 -0.53 -0.39 -0.88 0.26 -0.97 -
Basic Earnings per Share
($0.25) $0.04 ($0.32) ($0.08) ($0.08) ($0.08) ($0.08) ($0.10) ($0.10) ($0.12) -
Weighted Average Basic Shares Outstanding
318.46M 320.55M 315.51M 315.37M 310.91M 313.11M 307.74M 307.71M 303.28M 305.98M -
Diluted Earnings per Share
($0.24) $0.03 ($0.32) ($0.08) ($0.08) ($0.08) ($0.08) ($0.10) ($0.10) ($0.12) -
Weighted Average Diluted Shares Outstanding
318.46M 367.03M 315.51M 315.37M 310.91M 313.11M 307.74M 307.71M 303.28M 305.98M -
Weighted Average Basic & Diluted Shares Outstanding
325.21M 323.82M 323.82M 317.20M 317.21M 316.53M 316.31M 309.43M 309.41M 309.29M -

Annual Cash Flow Statements for Microvast

This table details how cash moves in and out of Microvast's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents
21 -214 -233
Net Cash From Operating Activities
2.81 -75 -54
Net Cash From Continuing Operating Activities
2.81 -75 -54
Net Income / (Loss) Continuing Operations
-195 -106 -158
Consolidated Net Income / (Loss)
-195 -106 -158
Provision For Loan Losses
3.74 0.24 1.64
Depreciation Expense
30 22 20
Amortization Expense
0.78 0.79 0.55
Non-Cash Adjustments to Reconcile Net Income
216 86 113
Changes in Operating Assets and Liabilities, net
-53 -78 -30
Net Cash From Investing Activities
-12 -166 -176
Net Cash From Continuing Investing Activities
-12 -166 -176
Purchase of Property, Leasehold Improvements and Equipment
-28 -187 -151
Purchase of Investment Securities
0.00 -5.97 -25
Sale of Property, Leasehold Improvements and Equipment
10 1.65 0.01
Sale and/or Maturity of Investments
5.56 26 0.00
Net Cash From Financing Activities
38 33 4.97
Net Cash From Continuing Financing Activities
38 33 4.97
Issuance of Debt
127 48 59
Repayment of Debt
-67 -15 -54
Other Financing Activities, Net
-22 0.00 0.00
Effect of Exchange Rate Changes
-6.84 -6.56 -8.59
Cash Interest Paid
7.44 4.37 5.14
Cash Income Taxes Paid
0.00 0.00 0.00

Quarterly Cash Flow Statements for Microvast

This table details how cash moves in and out of Microvast's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q1 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022
Net Change in Cash & Equivalents
-5.37 10 18 -1.49 -1.02 -81 -90 -42 -113 19 -
Net Cash From Operating Activities
6.10 -5.43 0.11 2.03 -4.95 -29 -30 -11 4.67 4.94 -
Net Cash From Continuing Operating Activities
6.10 -5.43 0.11 2.03 -4.95 -29 -30 -11 4.67 4.94 -
Net Income / (Loss) Continuing Operations
-82 -9.87 -102 -25 -25 -26 -26 -30 -34 -37 -
Consolidated Net Income / (Loss)
-82 -9.87 -102 -25 -25 -26 -26 -30 -34 -37 -
Provision For Loan Losses
3.98 -0.99 0.18 0.58 1.27 -0.21 0.26 -1.09 -1.85 1.19 -
Depreciation Expense
7.62 7.53 7.44 7.47 7.50 4.85 4.91 4.89 4.65 4.78 -
Amortization Expense
0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.21 0.13 0.14 -
Non-Cash Adjustments to Reconcile Net Income
81 35 108 16 21 21 23 22 29 23 -
Changes in Operating Assets and Liabilities, net
-4.29 -37 -14 2.89 -11 -29 -32 -7.52 6.20 13 -
Net Cash From Investing Activities
-0.18 -4.53 -2.92 -4.53 -12 -60 -58 -36 -91 -17 -
Net Cash From Continuing Investing Activities
-0.18 -4.53 -2.92 -4.53 -12 -60 -58 -36 -91 -17 -
Purchase of Property, Leasehold Improvements and Equipment
-0.36 -14 -2.95 -10 -33 -60 -58 -36 -66 -17 -
Sale of Property, Leasehold Improvements and Equipment
0.18 9.65 0.03 0.15 0.77 0.23 0.31 0.34 - - -
Net Cash From Financing Activities
-9.05 18 22 6.26 21 6.86 0.91 4.38 -29 38 -
Net Cash From Continuing Financing Activities
-9.05 18 22 6.26 21 6.86 0.91 4.38 -29 38 -
Issuance of Debt
31 43 34 19 29 9.21 4.85 4.38 - 45 -
Repayment of Debt
-34 -8.38 -11 -13 -8.53 -2.35 -3.94 0.00 -29 -7.15 -
Other Financing Activities, Net
-5.77 - - - - - - - - - -
Effect of Exchange Rate Changes
-2.24 2.30 -1.64 -5.25 -4.47 1.09 -3.65 0.47 2.74 -7.46 -

Annual Balance Sheets for Microvast

This table presents Microvast's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
952 1,097 985
Cash and Due from Banks
73 45 231
Restricted Cash
37 44 71
Loans and Leases, Net of Allowance
0.00 0.00 0.00
Premises and Equipment, Net
490 633 348
Intangible Assets
2.61 3.14 1.64
Other Assets
350 373 333
Total Liabilities & Shareholders' Equity
952 1,097 985
Total Liabilities
564 533 372
Short-Term Debt
231 254 131
Accrued Interest Payable
99 149 67
Other Short-Term Payables
0.01 0.00 54
Long-Term Debt
189 87 73
Other Long-Term Liabilities
45 42 47
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
388 564 613
Total Preferred & Common Equity
388 564 613
Total Common Equity
388 564 613
Common Stock
1,513 1,481 1,416
Retained Earnings
-1,093 -898 -791
Accumulated Other Comprehensive Income / (Loss)
-38 -26 -18
Other Equity Adjustments
6.03 6.03 6.03

Quarterly Balance Sheets for Microvast

This table presents Microvast's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Total Assets
998 961 1,041 1,017 998 1,004 973 999 - 990 282
Cash and Due from Banks
64 68 39 67 143 200 296 416 - 573 0.07
Restricted Cash
40 35 45 22 28 60 83 55 - 40 282
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Premises and Equipment, Net
516 508 628 561 510 456 299 285 - 237 -
Intangible Assets
2.79 2.85 2.99 3.21 3.34 3.69 1.70 1.82 - 2.02 -
Other Assets
375 348 325 363 314 284 294 241 - 139 0.04
Total Liabilities & Shareholders' Equity
998 961 1,041 1,017 998 1,004 973 999 - 990 282
Total Liabilities
512 506 495 449 418 398 357 341 - 274 6.67
Short-Term Debt
188 188 187 159 123 131 116 117 - 103 0.00
Accrued Interest Payable
105 143 138 122 117 94 80 61 - - -
Other Short-Term Payables
43 41 41 54 53 53 36 3.60 - 50 0.80
Long-Term Debt
121 91 86 75 75 73 82 73 - 73 1.69
Other Long-Term Liabilities
55 43 42 38 50 47 43 87 - 47 4.18
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Equity & Noncontrolling Interests
486 455 546 567 580 606 616 657 - 717 -6.47
Total Preferred & Common Equity
486 455 546 565 578 604 616 657 - 717 -6.47
Total Common Equity
486 455 546 565 578 604 616 657 - 717 -6.47
Common Stock
1,512 1,506 1,493 1,468 1,452 1,434 1,398 1,320 - 1,291 0.00
Retained Earnings
-1,011 -1,024 -922 -873 -847 -821 -757 -677 - -585 -6.48
Accumulated Other Comprehensive Income / (Loss)
-22 -33 -31 -36 -34 -16 -31 7.69 - 4.98 -
Other Equity Adjustments
6.03 6.03 6.03 6.03 6.03 6.03 6.03 6.03 - 6.03 -

Annual Metrics And Ratios for Microvast

This table displays calculated financial ratios and metrics derived from Microvast's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
23.62% 50.52% 33.44%
EBITDA Growth
-99.10% 40.35% 25.29%
EBIT Growth
-85.08% 33.58% 22.92%
NOPAT Growth
-83.70% 32.73% 23.40%
Net Income Growth
-83.68% 32.74% 23.38%
EPS Growth
-79.41% 34.62% 58.73%
Operating Cash Flow Growth
103.74% -39.64% -19.74%
Free Cash Flow Firm Growth
76.12% -208.86% 93.47%
Invested Capital Growth
-10.80% 10.88% -6.61%
Revenue Q/Q Growth
4.93% 13.39% -6.38%
EBITDA Q/Q Growth
-96.13% 13.94% 7.49%
EBIT Q/Q Growth
-70.50% 9.04% 7.16%
NOPAT Q/Q Growth
-70.56% 7.87% 7.76%
Net Income Q/Q Growth
-70.54% 7.88% 7.56%
EPS Q/Q Growth
-60.53% 5.56% -4.00%
Operating Cash Flow Q/Q Growth
134.15% -14.65% 31.72%
Free Cash Flow Firm Q/Q Growth
47.19% -139.63% -28.83%
Invested Capital Q/Q Growth
1.59% 12.98% 0.31%
Profitability Metrics
- - -
EBITDA Margin
-43.34% -26.91% -67.90%
EBIT Margin
-51.44% -34.36% -77.86%
Profit (Net Income) Margin
-51.40% -34.59% -77.42%
Tax Burden Percent
100.00% 100.01% 100.02%
Interest Burden Percent
99.92% 100.67% 99.41%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-15.97% -8.65% -13.09%
ROIC Less NNEP Spread (ROIC-NNEP)
-31.38% -20.36% -37.35%
Return on Net Nonoperating Assets (RNNOA)
-25.09% -9.43% -11.25%
Return on Equity (ROE)
-41.06% -18.08% -24.34%
Cash Return on Invested Capital (CROIC)
-4.55% -18.97% -6.26%
Operating Return on Assets (OROA)
-19.10% -10.15% -16.07%
Return on Assets (ROA)
-19.08% -10.22% -15.98%
Return on Common Equity (ROCE)
-41.06% -18.08% -24.34%
Return on Equity Simple (ROE_SIMPLE)
-50.39% -18.86% -25.81%
Net Operating Profit after Tax (NOPAT)
-137 -74 -111
NOPAT Margin
-35.98% -24.21% -54.18%
Net Nonoperating Expense Percent (NNEP)
15.41% 11.72% 24.26%
SG&A Expenses to Revenue
16.74% 22.31% 32.36%
Operating Expenses to Revenue
151.44% 134.36% 177.86%
Earnings before Interest and Taxes (EBIT)
-196 -106 -159
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-165 -83 -139
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.73 0.79 0.77
Price to Tangible Book Value (P/TBV)
1.74 0.79 0.77
Price to Revenue (P/Rev)
1.76 1.44 2.32
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.21 0.77 0.46
Enterprise Value to Revenue (EV/Rev)
2.58 2.26 1.83
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
348.46 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
1.08 0.61 0.33
Long-Term Debt to Equity
0.49 0.15 0.12
Financial Leverage
0.80 0.46 0.30
Leverage Ratio
2.15 1.77 1.52
Compound Leverage Factor
2.15 1.78 1.51
Debt to Total Capital
51.98% 37.70% 24.94%
Short-Term Debt to Total Capital
28.60% 28.10% 16.02%
Long-Term Debt to Total Capital
23.38% 9.60% 8.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
48.02% 62.30% 75.06%
Debt to EBITDA
-2.55 -4.13 -1.47
Net Debt to EBITDA
-1.88 -3.06 0.71
Long-Term Debt to EBITDA
-1.15 -1.05 -0.53
Debt to NOPAT
-3.07 -4.58 -1.84
Net Debt to NOPAT
-2.27 -3.40 0.89
Long-Term Debt to NOPAT
-1.38 -1.17 -0.66
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-39 -163 -53
Operating Cash Flow to CapEx
15.88% -40.67% -35.74%
Free Cash Flow to Firm to Interest Expense
-4.02 -62.17 -15.92
Operating Cash Flow to Interest Expense
0.29 -28.65 -16.23
Operating Cash Flow Less CapEx to Interest Expense
-1.53 -99.10 -61.63
Efficiency Ratios
- - -
Asset Turnover
0.37 0.30 0.21
Fixed Asset Turnover
0.68 0.63 0.66
Capital & Investment Metrics
- - -
Invested Capital
808 906 817
Invested Capital Turnover
0.44 0.36 0.24
Increase / (Decrease) in Invested Capital
-98 89 -58
Enterprise Value (EV)
981 696 375
Market Capitalization
670 443 473
Book Value per Share
$1.20 $1.78 $1.98
Tangible Book Value per Share
$1.19 $1.77 $1.98
Total Capital
808 906 817
Total Debt
420 341 204
Total Long-Term Debt
189 87 73
Net Debt
310 253 -98
Capital Expenditures (CapEx)
18 185 151
Net Nonoperating Expense (NNE)
59 32 47
Net Nonoperating Obligations (NNO)
420 341 204
Total Depreciation and Amortization (D&A)
31 23 20
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($0.61) ($0.34) ($0.52)
Adjusted Weighted Average Basic Shares Outstanding
318.46M 310.91M 303.28M
Adjusted Diluted Earnings per Share
($0.61) ($0.34) ($0.52)
Adjusted Weighted Average Diluted Shares Outstanding
318.46M 310.91M 303.28M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
325.21M 317.21M 309.41M
Normalized Net Operating Profit after Tax (NOPAT)
-17 -76 -111
Normalized NOPAT Margin
-4.60% -24.56% -54.47%
Pre Tax Income Margin
-51.40% -34.59% -77.40%
Debt Service Ratios
- - -
EBIT to Interest Expense
-20.14 -40.22 -47.88
NOPAT to Interest Expense
-14.09 -28.34 -33.32
EBIT Less CapEx to Interest Expense
-21.97 -110.67 -93.29
NOPAT Less CapEx to Interest Expense
-15.91 -98.79 -78.72
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Microvast

This table displays calculated financial ratios and metrics derived from Microvast's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q1 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
17.27% 21.29% 7.69% 66.49% 58.00% 107.19% 18.84% 32.36% -17.54% 16.35% -
EBITDA Growth
-361.61% 199.24% -347.69% 29.88% 45.76% 33.18% 46.17% 36.14% 27.36% 71.59% -
EBIT Growth
-245.56% 150.62% -289.43% 16.05% 31.04% 28.38% 40.98% 32.45% 26.17% 68.59% -
NOPAT Growth
-234.91% 172.31% -289.43% 16.05% 26.98% 28.38% 40.98% 32.45% 28.32% 68.60% -
Net Income Growth
-234.77% 150.62% -289.43% 16.05% 27.03% 28.38% 40.98% 32.45% 27.75% 68.63% -
EPS Growth
-200.00% 137.50% -300.00% 20.00% 20.00% 33.33% 46.67% 33.33% -25.00% 75.51% -
Operating Cash Flow Growth
223.18% 81.50% 100.37% 118.19% -206.13% -693.97% 22.73% 55.18% 122.89% 151.31% -
Free Cash Flow Firm Growth
137.88% 446.47% -148.60% -263.55% -409.73% -110.60% 109.45% 102.80% 104.91% 107.71% -
Invested Capital Growth
-10.80% -0.79% -5.56% 1.24% 10.88% -1.56% -8.87% -4.42% -6.61% -8.84% -
Revenue Q/Q Growth
24.78% 18.89% 2.62% -22.97% 29.06% 5.56% 58.65% -28.71% 69.23% -39.45% -
EBITDA Q/Q Growth
-456.06% 129.37% -447.29% -4.52% 23.45% -1.91% 14.28% 17.94% 5.69% 18.86% -
EBIT Q/Q Growth
-722.62% 116.76% -309.09% -2.96% 8.80% -1.30% 11.81% 14.56% 5.30% 17.29% -
NOPAT Q/Q Growth
-535.01% 124.13% -309.09% -0.99% 6.08% -0.36% 11.81% 12.16% 7.88% 17.29% -
Net Income Q/Q Growth
-721.45% 116.89% -309.09% -0.95% 6.04% -0.36% 11.81% 12.25% 7.79% 17.29% -
EPS Q/Q Growth
-900.00% 112.00% -300.00% 0.00% 0.00% 0.00% 20.00% 0.00% 16.67% 20.00% -
Operating Cash Flow Q/Q Growth
212.38% -4,990.99% -94.53% 141.01% 83.12% 1.68% -167.26% -339.25% -5.53% 112.79% -
Free Cash Flow Firm Q/Q Growth
104.95% 156.32% -1.59% 56.45% -1,774.75% -109.87% 241.85% -51.01% -35.84% 108.80% -
Invested Capital Q/Q Growth
1.59% 5.03% -10.47% -4.95% 12.98% 3.13% -4.02% -0.85% 0.31% -4.53% -
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
-61.51% 21.56% -114.78% -21.52% -15.63% -26.35% -27.61% -51.10% -45.52% -81.69% -
EBIT Margin
-67.95% 13.62% -124.11% -31.13% -23.06% -32.63% -34.32% -61.74% -52.83% -94.40% -
Profit (Net Income) Margin
-67.82% 13.62% -124.11% -31.13% -23.76% -32.63% -34.32% -61.74% -51.44% -94.40% -
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.04% 100.00% 100.00% 100.00% 100.10% 100.00% -
Interest Burden Percent
99.81% 100.00% 100.00% 100.00% 102.99% 100.00% 100.00% 100.00% 97.27% 100.00% -
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Return on Invested Capital (ROIC)
-21.07% 6.18% -39.70% -9.08% -5.94% -7.67% -6.77% -11.36% -8.69% -16.90% -
ROIC Less NNEP Spread (ROIC-NNEP)
-27.56% 6.18% -52.49% -12.20% -8.65% -11.30% -10.72% -15.86% -13.87% -22.75% -
Return on Net Nonoperating Assets (RNNOA)
-22.04% 3.19% -24.17% -5.06% -4.00% -4.13% -3.44% -4.94% -4.18% -6.40% -
Return on Equity (ROE)
-43.11% 9.37% -63.87% -14.14% -9.94% -11.80% -10.22% -16.30% -12.87% -23.29% -
Cash Return on Invested Capital (CROIC)
-4.55% -9.25% -10.69% -9.97% -18.97% -8.44% -1.53% -7.64% -6.26% -4.81% -
Operating Return on Assets (OROA)
-25.22% 4.90% -43.75% -10.34% -6.81% -8.90% -8.01% -13.43% -10.90% -20.99% -
Return on Assets (ROA)
-25.18% 4.90% -43.75% -10.34% -7.02% -8.90% -8.01% -13.43% -10.62% -20.99% -
Return on Common Equity (ROCE)
-43.11% 9.35% -63.75% -14.11% -9.94% -11.78% -10.20% -16.28% -12.87% -23.29% -
Return on Equity Simple (ROE_SIMPLE)
0.00% -23.58% -38.93% -18.62% 0.00% -20.43% -21.79% -23.85% 0.00% -27.79% -
Net Operating Profit after Tax (NOPAT)
-58 13 -71 -17 -17 -18 -18 -21 -24 -26 -
NOPAT Margin
-47.47% 13.62% -86.88% -21.79% -16.62% -22.84% -24.02% -43.22% -35.97% -66.08% -
Net Nonoperating Expense Percent (NNEP)
6.49% 0.00% 12.79% 3.12% 2.71% 3.63% 3.95% 4.51% 5.18% 5.85% -
SG&A Expenses to Revenue
12.99% 16.09% 18.49% 21.42% 17.48% 24.03% 20.27% 33.09% 24.03% 43.96% -
Operating Expenses to Revenue
167.95% 86.38% 224.11% 131.13% 123.06% 132.63% 134.32% 161.74% 152.83% 194.40% -
Earnings before Interest and Taxes (EBIT)
-82 13 -102 -25 -24 -26 -26 -30 -35 -37 -
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-75 21 -94 -17 -16 -21 -21 -24 -30 -32 -
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.73 0.17 0.32 0.49 0.79 1.06 0.86 0.64 0.77 0.89 -
Price to Tangible Book Value (P/TBV)
1.74 0.17 0.32 0.49 0.79 1.06 0.86 0.64 0.77 0.89 -
Price to Revenue (P/Rev)
1.76 0.22 0.42 0.78 1.44 2.20 2.15 1.76 2.32 2.51 -
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Enterprise Value to Invested Capital (EV/IC)
1.21 0.36 0.44 0.55 0.77 0.93 0.67 0.41 0.46 0.45 -
Enterprise Value to Revenue (EV/Rev)
2.58 0.79 0.93 1.34 2.26 2.75 2.28 1.51 1.83 1.68 -
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Enterprise Value to Operating Cash Flow (EV/OCF)
348.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.08 0.64 0.61 0.50 0.61 0.41 0.34 0.34 0.33 0.32 -
Long-Term Debt to Equity
0.49 0.25 0.20 0.16 0.15 0.13 0.13 0.12 0.12 0.13 -
Financial Leverage
0.80 0.52 0.46 0.41 0.46 0.37 0.32 0.31 0.30 0.28 -
Leverage Ratio
2.15 1.91 1.89 1.77 1.77 1.68 1.60 1.59 1.52 1.47 -
Compound Leverage Factor
2.15 1.91 1.89 1.77 1.82 1.68 1.60 1.59 1.48 1.47 -
Debt to Total Capital
51.98% 38.87% 38.01% 33.38% 37.70% 29.22% 25.41% 25.18% 24.94% 24.36% -
Short-Term Debt to Total Capital
28.60% 23.65% 25.66% 22.87% 28.10% 19.89% 15.77% 16.16% 16.02% 14.31% -
Long-Term Debt to Total Capital
23.38% 15.21% 12.35% 10.51% 9.60% 9.32% 9.64% 9.02% 8.92% 10.05% -
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.25% 0.26% 0.27% 0.00% 0.00% -
Common Equity to Total Capital
48.02% 61.13% 61.99% 66.62% 62.30% 70.54% 74.33% 74.55% 75.06% 75.64% -
Debt to EBITDA
-2.55 -3.68 -1.88 -3.63 -4.13 -2.44 -1.85 -1.63 -1.47 -1.32 -
Net Debt to EBITDA
-1.88 -2.44 -1.19 -2.51 -3.06 -1.51 -0.25 0.45 0.71 1.20 -
Long-Term Debt to EBITDA
-1.15 -1.44 -0.61 -1.14 -1.05 -0.78 -0.70 -0.58 -0.53 -0.55 -
Debt to NOPAT
-3.07 -3.85 -2.25 -3.85 -4.58 -2.90 -2.24 -2.02 -1.84 -1.65 -
Net Debt to NOPAT
-2.27 -2.56 -1.42 -2.66 -3.40 -1.79 -0.31 0.56 0.89 1.51 -
Long-Term Debt to NOPAT
-1.38 -1.51 -0.73 -1.21 -1.17 -0.92 -0.85 -0.72 -0.66 -0.68 -
Noncontrolling Interest Sharing Ratio
0.00% 0.19% 0.20% 0.19% 0.00% 0.17% 0.17% 0.17% 0.00% 0.00% -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
40 20 -28 -27 -106 -5.66 57 17 34 53 -
Operating Cash Flow to CapEx
3,389.44% -119.85% 3.81% 20.13% -15.27% -49.14% -51.99% -31.38% 7.05% 29.39% -
Free Cash Flow to Firm to Interest Expense
25.19 4.57 -13.31 -15.85 -89.08 -11.53 117.79 36.56 39.92 68.98 -
Operating Cash Flow to Interest Expense
3.83 -1.27 0.05 1.17 -4.16 -59.76 -61.28 -24.33 5.44 6.38 -
Operating Cash Flow Less CapEx to Interest Expense
3.71 -2.32 -1.34 -4.65 -31.40 -181.37 -179.14 -101.85 -71.67 -15.33 -
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.37 0.36 0.35 0.33 0.30 0.27 0.23 0.22 0.21 0.22 -
Fixed Asset Turnover
0.68 0.67 0.68 0.63 0.63 0.63 0.56 0.59 0.66 0.82 -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
808 795 734 820 906 802 777 810 817 814 -
Invested Capital Turnover
0.44 0.45 0.46 0.42 0.36 0.34 0.28 0.26 0.24 0.26 -
Increase / (Decrease) in Invested Capital
-98 -6.36 -43 10 89 -13 -76 -37 -58 -79 -
Enterprise Value (EV)
981 286 321 454 696 745 524 329 375 367 -
Market Capitalization
670 81 145 265 443 598 495 384 473 548 -
Book Value per Share
$1.20 $1.50 $1.43 $1.73 $1.78 $1.79 $1.87 $1.95 $1.98 $2.04 -
Tangible Book Value per Share
$1.19 $1.49 $1.43 $1.72 $1.77 $1.78 $1.86 $1.94 $1.98 $2.03 -
Total Capital
808 795 734 820 906 802 777 810 817 814 -
Total Debt
420 309 279 274 341 234 197 204 204 198 -
Total Long-Term Debt
189 121 91 86 87 75 75 73 73 82 -
Net Debt
310 205 176 190 253 145 27 -57 -98 -181 -
Capital Expenditures (CapEx)
0.18 4.53 2.92 10 32 60 57 36 66 17 -
Net Nonoperating Expense (NNE)
25 0.00 30 7.45 7.38 7.85 7.82 8.87 10 11 -
Net Nonoperating Obligations (NNO)
420 309 279 274 341 234 197 204 204 198 -
Total Depreciation and Amortization (D&A)
7.81 7.72 7.64 7.66 7.69 5.04 5.10 5.10 4.78 4.92 -
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.25) $0.04 ($0.32) ($0.08) ($0.08) ($0.08) ($0.08) ($0.10) ($0.10) ($0.12) -
Adjusted Weighted Average Basic Shares Outstanding
318.46M 320.55M 315.51M 315.37M 310.91M 313.11M 307.74M 307.71M 303.28M 305.98M -
Adjusted Diluted Earnings per Share
($0.24) $0.03 ($0.32) ($0.08) ($0.08) ($0.08) ($0.08) ($0.10) ($0.10) ($0.12) -
Adjusted Weighted Average Diluted Shares Outstanding
318.46M 367.03M 315.51M 315.37M 310.91M 313.11M 307.74M 307.71M 303.28M 305.98M -
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -
Adjusted Weighted Average Basic & Diluted Shares Outstanding
325.21M 323.82M 323.82M 317.20M 317.21M 316.53M 316.31M 309.43M 309.41M 309.29M -
Normalized Net Operating Profit after Tax (NOPAT)
4.50 1.41 -9.31 -18 -17 -18 -18 -21 -23 -26 -
Normalized NOPAT Margin
3.71% 1.45% -11.38% -22.18% -16.76% -22.93% -24.34% -44.51% -35.69% -67.83% -
Pre Tax Income Margin
-67.82% 13.62% -124.11% -31.13% -23.75% -32.63% -34.32% -61.74% -51.39% -94.40% -
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-51.71 3.09 -48.50 -14.33 -20.04 -53.30 -53.55 -64.42 -40.34 -47.21 -
NOPAT to Interest Expense
-36.13 3.09 -33.95 -10.03 -14.45 -37.31 -37.48 -45.10 -27.47 -33.05 -
EBIT Less CapEx to Interest Expense
-51.82 2.03 -49.89 -20.16 -47.28 -174.92 -171.41 -141.95 -117.44 -68.93 -
NOPAT Less CapEx to Interest Expense
-36.24 2.03 -35.34 -15.86 -41.69 -158.93 -155.35 -122.62 -104.57 -54.76 -
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -

Frequently Asked Questions About Microvast's Financials

When does Microvast's fiscal year end?

According to the most recent income statement we have on file, Microvast's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Microvast's net income changed over the last 2 years?

Microvast's net income appears to be on an upward trend, with a most recent value of -$195.46 million in 2024, rising from -$158.20 million in 2022. The previous period was -$106.41 million in 2023.

How has Microvast revenue changed over the last 2 years?

Over the last 2 years, Microvast's total revenue changed from $204.35 million in 2022 to $380.24 million in 2024, a change of 86.1%.

How much debt does Microvast have?

Microvast's total liabilities were at $563.97 million at the end of 2024, a 5.9% increase from 2023, and a 51.6% increase since 2022.

How much cash does Microvast have?

In the past 2 years, Microvast's cash and equivalents has ranged from $44.54 million in 2023 to $231.42 million in 2022, and is currently $73.01 million as of their latest financial filing in 2024.

How has Microvast's book value per share changed over the last 2 years?

Over the last 2 years, Microvast's book value per share changed from 1.98 in 2022 to 1.20 in 2024, a change of -39.6%.



This page (NASDAQ:MVSTW) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners